No abstract available
MeSH terms
-
Adalimumab
-
Adult
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal, Humanized
-
Aza Compounds / administration & dosage
-
Chronic Disease
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Etanercept
-
Familial Mediterranean Fever / diagnosis*
-
Familial Mediterranean Fever / drug therapy*
-
Female
-
Fluoroquinolones
-
Follow-Up Studies
-
Humans
-
Immunoglobulin G / administration & dosage*
-
Male
-
Middle Aged
-
Moxifloxacin
-
Prospective Studies
-
Quinolines / administration & dosage
-
Receptors, Tumor Necrosis Factor / administration & dosage*
-
Receptors, Tumor Necrosis Factor, Type I / adverse effects*
-
Receptors, Tumor Necrosis Factor, Type I / metabolism*
-
Risk Assessment
-
Severity of Illness Index
-
Time Factors
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Aza Compounds
-
Fluoroquinolones
-
Immunoglobulin G
-
Quinolines
-
Receptors, Tumor Necrosis Factor
-
Receptors, Tumor Necrosis Factor, Type I
-
Adalimumab
-
Etanercept
-
Moxifloxacin